Division of Cardiology, Japanese Red Cross Otsu Hospital, Otsu 520-8511, Japan; Department of Cardiology, Tenri Hospital, Tenri 632-0015, Japan.
Division of Cardiology, Japanese Red Cross Otsu Hospital, Otsu 520-8511, Japan; Department of Cardiology, Tenri Hospital, Tenri 632-0015, Japan.
Int J Cardiol. 2021 Oct 15;341:39-45. doi: 10.1016/j.ijcard.2021.07.053. Epub 2021 Jul 31.
The relationship between the timing of the first early recurrence and late recurrence after a single catheter ablation procedure for atrial fibrillation is controversial.
The Efficacy of Short-Term Use of Antiarrhythmic Drugs After Catheter Ablation for Atrial Fibrillation trial followed 2038 patients who underwent radiofrequency catheter ablation for atrial fibrillation.
Of the patients, 907 (45%) had early recurrences within 90 days after the initial ablation. We divided these patients into two groups according to the timing of the first early recurrence episode, namely the ER group (early recurrence during the early phase; 0-30 days, n = 814) and ER group (early recurrence during the late phase; 31-90 days, n = 93). Three years after ablation, patients with early recurrences had a significantly lower event-free rate from late recurrences after a 90-day blanking period than patients without early recurrences (36.2% and 74.2%, respectively; log-rank, P < 0.0001). Three years after ablation, the event-free rate was significantly higher in the ER than the ER group (38.3% and 17.1%, respectively; log-rank, P < 0.0001). Moreover, the event-free rate at 3 years in the ER group was extremely low (5.6%) in patient with non-paroxysmal atrial fibrillation.
Early recurrences were strongly associated with late recurrences, especially in patients with the first recurrence episode at >1 month within the blanking period after a single ablation procedure. Therefore, these patients should undergo close observation during follow-up, when they had especially with non-paroxysmal atrial fibrillation.
单次导管消融术后早期复发与晚期复发之间的关系存在争议。
房颤导管消融后短期应用抗心律失常药物的疗效试验纳入了 2038 例接受射频导管消融治疗的房颤患者。
在这些患者中,907 例(45%)在初始消融后 90 天内出现早期复发。我们根据首次早期复发的时间将这些患者分为两组,即早期复发组(早期复发;0-30 天,n=814)和晚期复发组(晚期复发;31-90 天,n=93)。消融后 3 年,与无早期复发的患者相比,早期复发且经过 90 天空白期的患者晚期复发无事件生存率显著降低(分别为 36.2%和 74.2%;log-rank,P<0.0001)。消融后 3 年,早期复发组的无事件生存率显著高于晚期复发组(分别为 38.3%和 17.1%;log-rank,P<0.0001)。此外,在非阵发性房颤患者中,早期复发组 3 年的无事件生存率极低(5.6%)。
早期复发与晚期复发密切相关,尤其是在首次复发发生在消融后 1 个月内的空白期的患者中。因此,这些患者在随访期间应密切观察,尤其是在患有非阵发性房颤的患者中。